Patents by Inventor Natalie Herzog

Natalie Herzog has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10036052
    Abstract: This invention relates to a biogenic substance production process wherein a) at least one starting material has b) at least one enzyme added to it and the product resulting from b) has c) at least one liver cell added to it, and d) at least one biogenic substance is isolated.
    Type: Grant
    Filed: November 11, 2014
    Date of Patent: July 31, 2018
    Assignee: Brandenburgische Technische Universität Cottbus-Senftenberg
    Inventors: Katrin Scheibner, Jan-Heiner Küpper, Kai-Uwe Schmidtke, Sebastian Miethbauer, Natalie Herzog
  • Publication number: 20160289724
    Abstract: This invention relates to a biogenic substance production process wherein a) at least one starting material has b) at least one enzyme added to it and the product resulting from b) has c) at least one liver cell added to it, and d) at least one biogenic substance is isolated.
    Type: Application
    Filed: November 11, 2014
    Publication date: October 6, 2016
    Inventors: Katrin SCHEIBNER, Jan-Heiner KÜPPER, Kai-Uwe SCHMIDTKE, Sebastian MIETHBAUER, Natalie HERZOG
  • Publication number: 20150118291
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Application
    Filed: December 12, 2014
    Publication date: April 30, 2015
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Publication number: 20140056970
    Abstract: A method for preparing amphoteric liposomes loaded with a polyanionic active agent as cargo, characterised by admixing an aqueous solution of said polyanionic active agent and an alcoholic solution of one or more amphiphiles and buffering said admixture to an acidic pH, said one or more amphiphiles being susceptible of forming amphoteric liposomes at said acidic pH, thereby to form such amphoteric liposomes in suspension encapsulating said active agent under conditions such that said liposomes form aggregates, and thereafter treating said suspension to dissociate said aggregates. Also disclosed are nucleic acid loaded amphoteric liposomes produced in accordance with the method, wherein said nucleic acids are oligonucleotides and said liposomes are multilamellar.
    Type: Application
    Filed: October 29, 2013
    Publication date: February 27, 2014
    Applicant: Marina Biotech, Inc.
    Inventors: Steffen Panzner, Gerold Endert, Una Rauchhaus, Natalie Herzog, Claudia Muller
  • Publication number: 20130323298
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Application
    Filed: January 28, 2013
    Publication date: December 5, 2013
    Applicants: Novosom AG, ProNAi Therapeutics, Inc.
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Patent number: 8367628
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: February 5, 2013
    Assignees: ProNAi Therapeutics, Inc., Novosom AG
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Publication number: 20120021042
    Abstract: A method for preparing amphoteric liposomes loaded with polyanionic active agent as cargo, characterised by admixing an aqueous solution of said polyanionic active agent and an alcoholic solution of one or more amphiphiles and buffering said admixture to an acidic pH, said one or more amphiphiles being susceptible of forming amphoteric liposomes at said acidic pH, thereby to form such amphoteric liposomes in suspension encapsulating said active agent under conditions such that said liposomes form aggregates, and thereafter treating said suspension to dissociate said aggregates. Also disclosed are nucleic acid loaded amphoteric liposomes produced in accordance with the method, wherein said nucleic acids are oligonucleotides and said liposomes are multilamellar.
    Type: Application
    Filed: March 16, 2007
    Publication date: January 26, 2012
    Inventors: Steffen Panzner, Gerold Endert, Una Rauchhaus, Natalie Herzog, Claudia Muller
  • Publication number: 20090220584
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Application
    Filed: December 1, 2006
    Publication date: September 3, 2009
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza